1. Kyle RA, Bayrd ED: Amyloidosis: Review of 236 Cases. Medicine 1975 Jul; 54(4):271-99.

2. Henry RB 3rd et al: Vascular amyloid in a patient with multiple myeloma. J Am Acad Dermatol 1986 Aug;15(2 Pt 2):379-82.

3. Fanti PA et al: Nail changes as the first sign of systemic amyloidosis. Dermatologia 1991;183(1):44-6.

4. Wheeler GE, Barrows GH: Alopecia Universalis. A manifestation of occult amyloidosis and multiple myeloma. Arch Dermatol 1981 Dec;117(12):815-6.

5. Johnson TM et al: Bullous amyloidosis. Cutis 1989 Apr;43(4):346-52.

6. Breathnach SM: Amyloid and amyloidosis. J Am Acad Dermatol 1988 Jan;18(1 Pt 1):1-16.

7. Breathnach SM et al: Systemic amyloidosis with an underlying lymphoproliferative disorder. Report of a case in which nail involvement was a presenting feature. Clin Exp Dermatol 1979 Dec;4(4):495-9.

8. Wheeler GE, Barrows GH: Alopecia Universalis. A manifestation of occult amyloidosis and multiple myeloma. Arch Dermatol 1981 Dec;117(12):815-6.

9. Moreau P et al: Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients: Br J Haematol 1998 Jun;101(4):766-9.

10. Duston MA et al: Diagnosis of amyloidosis by abdominal fat pad aspiration. Analysis of four years' experience. Am J Med 1987 Mar;82(3):412-4.

11. Libbey CA et al: Use of abdominal fat pad aspirate in the diagnosis of systemic amyloidosis. Arch Int Med 1983 Aug;143(8):1549-52.

12. Blum A, Sohar E: The diagnosis of amyloidosis. Ancillary procedures. Lancet 1962 Apr;1(7232):721-3.

13. Kyle RA, Bayrd ED: Amyloidosis: Review of 236 Cases. Medicine 1975 Jul; 54(4):271-99.

14. Kyle RA, Bayrd ED: Amyloidosis: Review of 236 Cases. Medicine 1975 Jul; 54(4):271-99.

15. Duston MA et al: Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum 1980 Jan;32(1):82-5.

16. Kyle RA et al: A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine. N Engl J Med 1997 Apr;336(17):1202-7.

17. Comenzo RL et al: Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light chain) amyloidosis: survival and responses in 25 patients. Blood 1998 May;91(10):3662-70.

18. Comenzo RL: Primary Systemic Amyloidosis. Curr Treat Options Oncol. 2000 Apr:1(1):83-9.

19. Kumar KS, Lefkowitch J, Russo MW, Hesdorffer C, Kinkhabwala M, Kapur S, Emond JC, Brown RS Jr: Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. Gastroenterology. 2002 Jun;122(7):2026-31.

20. Mohty M, Albat B, Fegueux N, Rossi JF: Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis. Leuk Lymphoma. 2001 Mar;41(1-2):221-3.

21. Nowak G, Westermark P, Wernerson A, Herlenius G, Sletten K, Ericzon BG. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int. 2000;13(2):92-7.